Sentinel Oncology Limited – Product Pipeline Review – 2012 - This pharmaceuticals report, "Sentinel Oncology Limited - Product Pipeline Review - 2012" provides data on the Sentinel Oncology Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, Sentinel Oncology Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Sentinel Oncology Limited and industry-specific third party sources, put together by our team.

Scope

- Sentinel Oncology Limited - Brief Sentinel Oncology Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sentinel Oncology Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sentinel Oncology Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sentinel Oncology Limited's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Sentinel Oncology Limited's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sentinel Oncology Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sentinel Oncology Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sentinel Oncology Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sentinel Oncology Limited and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Sentinel Oncology Limited; Sentinel Oncology Limited - Key Therapeutics; Sentinel Oncology Limited - Pipeline Overview and Promising Molecules; Sentinel Oncology Limited - News; Sentinel Oncology Limited - Latest Updates; Sentinel Oncology Limited - Pipeline; Sentinel Oncology Limited - Discontinued/Dormant Projects

Click for Report details:Sentinel Oncology Limited - Product Pipeline Review - 2012